Involvement of μ-receptors in the opioid-induced generation of bursting discharges in hippocampal pyramidal cells

[1]  B. Gähwiler.  Development of acute tolerance during exposure of hippocampal explants to an opoid peptide , 1981, Brain Research.

[2]  B. Gähwiler,et al.  Effects of opioid peptides on synaptic potentials in explants of rat hippocampus , 1981, Regulatory Peptides.

[3]  H. Kosterlitz,et al.  Characterization of opioid receptors in nervous tissue , 1980, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[4]  T. Petcher,et al.  Bremazocine: a potent, long-acting opiate kappa-agonist. , 1980, Life sciences.

[5]  R. Nicoll,et al.  Enkephalin blocks inhibitory pathways in the vertebrate CNS , 1980, Nature.

[6]  B. H. Ga¨hwiler.  Excitatory action of opioid peptides and opiates on cultured hippocampal pyramidal cells , 1980, Brain Research.

[7]  F. Bloom,et al.  Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. , 1979, Science.

[8]  P. Cuatrecasas,et al.  Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. , 1979, Molecular pharmacology.

[9]  F. Cardinaux,et al.  A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity , 1977, Nature.

[10]  F. Bloom,et al.  Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Martin,et al.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[12]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.